239 related articles for article (PubMed ID: 32910548)
21. Identification of LINC01615 as potential metastasis-related long noncoding RNA in hepatocellular carcinoma.
Ji D; Chen GF; Liu X; Zhu J; Sun JY; Zhang XY; Lu XJ
J Cell Physiol; 2019 Aug; 234(8):12964-12970. PubMed ID: 30556902
[TBL] [Abstract][Full Text] [Related]
22. Predicting the immunity landscape and prognosis with an NCLs signature in liver hepatocellular carcinoma.
Ji Z; Zhang C; Yuan J; He Q; Zhang X; Yang D; Xu N; Chu J
PLoS One; 2024; 19(4):e0298775. PubMed ID: 38662757
[TBL] [Abstract][Full Text] [Related]
23. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
Ma Y; Luo T; Dong D; Wu X; Wang Y
Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
[TBL] [Abstract][Full Text] [Related]
24. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq.
Zhang Z; Li Y; Quan Z; Li Y; Zhu L; Sun S; Chen X
Front Immunol; 2024; 15():1397541. PubMed ID: 38774870
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
Gong X; Wei W; Chen L; Xia Z; Yu C
Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
[TBL] [Abstract][Full Text] [Related]
26. Investigation of Hippo pathway-related prognostic lncRNAs and molecular subtypes in liver hepatocellular carcinoma.
Su Q; Hua F; Xiao W; Liu B; Wang D; Qin X
Sci Rep; 2023 Mar; 13(1):4521. PubMed ID: 36941336
[TBL] [Abstract][Full Text] [Related]
27. Immune-related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma.
Zhang Y; Zhang L; Xu Y; Wu X; Zhou Y; Mo J
J Cell Physiol; 2020 Dec; 235(12):9304-9316. PubMed ID: 32330311
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential.
Fang TT; Sun XJ; Chen J; Zhao Y; Sun RX; Ren N; Liu BB
Asian Pac J Cancer Prev; 2014; 15(23):10513-24. PubMed ID: 25556502
[TBL] [Abstract][Full Text] [Related]
29. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.
El Khodiry A; Afify M; El Tayebi HM
World J Gastroenterol; 2018 Feb; 24(5):549-572. PubMed ID: 29434445
[TBL] [Abstract][Full Text] [Related]
30. Gene amplification derived a cancer-testis long noncoding RNA PCAT6 regulates cell proliferation and migration in hepatocellular carcinoma.
Chen S; Chen Y; Qian Q; Wang X; Chang Y; Ju S; Xu Y; Zhang C; Qin N; Ding H; Gu Y; Han J; Wang C; Zhang E; Hu Z
Cancer Med; 2019 Jun; 8(6):3017-3025. PubMed ID: 30968586
[TBL] [Abstract][Full Text] [Related]
31. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
32. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
[TBL] [Abstract][Full Text] [Related]
33. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
Tang P; Qu W; Wang T; Liu M; Wu D; Tan L; Zhou H
Front Genet; 2021; 12():785185. PubMed ID: 34917132
[No Abstract] [Full Text] [Related]
34. Type-1 Na
Zhou YT; Chen H; Ai M; Li SS; Li BY; Zhao Y; Cai WW; Hou B; Ni LL; Xu F; Qiu LY
Life Sci; 2021 Aug; 278():119613. PubMed ID: 34000263
[TBL] [Abstract][Full Text] [Related]
35. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
[TBL] [Abstract][Full Text] [Related]
36. Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing to chemotherapy and targeted therapy in liver hepatocellular carcinoma.
Pan Y; Zhu Q; Hong T; Cheng J; Tang X
Aging (Albany NY); 2024 May; 16(10):9047-9071. PubMed ID: 38787389
[TBL] [Abstract][Full Text] [Related]
37. Development of an immune-related prognostic index associated with hepatocellular carcinoma.
Hu B; Yang XB; Sang XT
Aging (Albany NY); 2020 Mar; 12(6):5010-5030. PubMed ID: 32191631
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNAs: critical players in hepatocellular carcinoma.
Sun J; Bie B; Zhang S; Yang J; Li Z
Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
[TBL] [Abstract][Full Text] [Related]
39. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
[TBL] [Abstract][Full Text] [Related]
40. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.
Bai KH; He SY; Shu LL; Wang WD; Lin SY; Zhang QY; Li L; Cheng L; Dai YJ
Cancer Med; 2020 Jun; 9(12):4290-4298. PubMed ID: 32311840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
